OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in lipid-modifying agent use in 83 countries
Joseph E. Blais, Yue Wei, Kevin K.W. Yap, et al.
Atherosclerosis (2021) Vol. 328, pp. 44-51
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

The Multifaceted Biology of PCSK9
Nabil G. Seidah, Annik Prat
Endocrine Reviews (2021) Vol. 43, Iss. 3, pp. 558-582
Open Access | Times Cited: 140

Epidemiology of Coronary Artery Disease
John Duggan, Alex S. Peters, Gregory D. Trachiotis, et al.
Surgical Clinics of North America (2022) Vol. 102, Iss. 3, pp. 499-516
Closed Access | Times Cited: 134

Repurposing pitavastatin and atorvastatin to overcome chemoresistance of metastatic colorectal cancer under high glucose conditions
Wei-Ming Cheng, Po-Chen Li, Minh Tran-Binh Nguyen, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2

Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis
Laura Álvarez-Jiménez, Félix Morales-Palomo, Alfonso Moreno‐Cabañas, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175672-175672
Open Access | Times Cited: 34

Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study
Adrienne Chan, Tiantian Ma, Wallis C. Y. Lau, et al.
EClinicalMedicine (2023) Vol. 58, pp. 101780-101780
Open Access | Times Cited: 33

Statin initiation and risk of incident kidney disease in patients with diabetes
Shiyu Zhou, Licong Su, Ruqi Xu, et al.
Canadian Medical Association Journal (2023) Vol. 195, Iss. 21, pp. E729-E738
Open Access | Times Cited: 30

New insights into the therapeutic potentials of statins in cancer
Chengyu Liu, Hong Chen, Bicheng Hu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23

The Structure of ApoB100 from Human Low-density Lipoprotein
Zachary T. Berndsen, C. Keith Cassidy
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5

Comparing the effects of CETP in East Asian and European ancestries: a Mendelian randomization study
Diana Dunca, Sandesh Chopade, María Gordillo‐Marañón, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
M. Nowak, Mariusz Niemczyk, Michał Florczyk, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5643-5643
Open Access | Times Cited: 24

Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015–2020
Jenny S. Guadamuz, Andrew Shooshtari, Dima M. Qato
BMJ Open (2022) Vol. 12, Iss. 9, pp. e061350-e061350
Open Access | Times Cited: 23

Clinical determinants of ischemic heart disease in Eastern Europe
Edina Cenko, Olivia Manfrini, Natalia Fabin, et al.
The Lancet Regional Health - Europe (2023) Vol. 33, pp. 100698-100698
Open Access | Times Cited: 14

Orally Administered Drugs and Their Complicated Relationship with Our Gastrointestinal Tract
Stavros Bashiardes, Christina Christodoulou
Microorganisms (2024) Vol. 12, Iss. 2, pp. 242-242
Open Access | Times Cited: 5

Combined effects of a pharmaceutical pollutant, gemfibrozil, and abiotic stressors (warming and air exposure) on cellular stress responses of the blue mussels Mytilus edulis
Halina Falfushynska, Eugene P. Sokolov, Inna M. Sokolova
Aquatic Toxicology (2025) Vol. 279, pp. 107233-107233
Closed Access

Personalized Statin Therapy: Targeting Metabolic Processes to Modulate the Therapeutic and Adverse Effects of Statins
Zhuangqi Shi, Shuxin Han
Heliyon (2025) Vol. 11, Iss. 1, pp. e41629-e41629
Closed Access

Updating the Scottish national cardiovascular risk score: ASSIGN version 2.0
Paul Welsh, Dorien M. Kimenai, Mark Woodward
Heart (2025), pp. heartjnl-324852
Closed Access

Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access

Uncovering Protein Prenylation in Th1 Cells: Novel Prenylation Sites and Insights into Statin and Farnesyltransferase Inhibition
Jana Koch, Alessandra Ruggia, Carina Beha, et al.
Research Square (Research Square) (2025)
Closed Access

Molecular mechanisms underlying the effects of statins on bone metabolism: an evolving paradigm of statins delivery modalities for bone regeneration
Randa Mohammed Zaki, Mohamed A. M. Ali, Mayada Said, et al.
Pharmacological Reports (2025)
Closed Access

Global, regional and national burden of alopecia areata and its associated diseases, 1990–2019: A systematic analysis of the Global Burden of Disease Study 2019
Hyeokjoo Jang, Seoyeon Park, Min Seo Kim, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 6
Closed Access | Times Cited: 11

Effects of cereal bran consumption on cardiometabolic risk factors: A systematic review and meta-analysis
Ruiting Zhu, Haiyan Xu, Hong Cai, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 33, Iss. 10, pp. 1849-1865
Closed Access | Times Cited: 11

Post-Marketing Surveillance of Statins—A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance
Gabriela Pop, Andreea Farcaș, Anca Butucă, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1536-1536
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top